Pacer Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-81,332
| Closed | -$14.9M | – | 1477 |
|
|
2021
Q2 | $14.9M | Buy |
81,332
+24,349
| +43% | +$4.47M | 0.21% | 70 |
|
|
2021
Q1 | $8.71M | Sell |
56,983
-1,412
| -2% | -$216K | 0.15% | 103 |
|
|
2020
Q4 | $9.12M | Sell |
58,395
-13,819
| -19% | -$2.16M | 0.17% | 88 |
|
|
2020
Q3 | $8.26M | Sell |
72,214
-1,429
| -2% | -$164K | 0.18% | 96 |
|
|
2020
Q2 | $8.27M | Buy |
73,643
+18,181
| +33% | +$2.04M | 0.17% | 105 |
|
|
2020
Q1 | $5.74M | Buy |
55,462
+38,030
| +218% | +$3.94M | 0.12% | 68 |
|
|
2019
Q4 | $1.89M | Sell |
17,432
-23,553
| -57% | -$2.55M | 0.09% | 283 |
|
|
2019
Q3 | $4.01M | Buy |
40,985
+4,433
| +12% | +$434K | 0.09% | 228 |
|
|
2019
Q2 | $4.79M | Buy |
36,552
+4,118
| +13% | +$539K | 0.12% | 160 |
|
|
2019
Q1 | $4.38M | Buy |
+32,434
| New | +$4.38M | 0.12% | 149 |
|
|
2018
Q4 | – | Sell |
-22,495
| Closed | -$3.13M | – | 1133 |
|
|
2018
Q3 | $3.13M | Buy |
22,495
+4,994
| +29% | +$694K | 0.12% | 165 |
|
|
2018
Q2 | $2.17M | Buy |
17,501
+3,070
| +21% | +$381K | 0.1% | 241 |
|
|
2018
Q1 | $1.61M | Buy |
14,431
+1,714
| +13% | +$191K | 0.09% | 274 |
|
|
2017
Q4 | $1.52M | Buy |
12,717
+5,033
| +65% | +$602K | 0.11% | 242 |
|
|
2017
Q3 | $1.08M | Buy |
7,684
+942
| +14% | +$132K | 0.1% | 263 |
|
|
2017
Q2 | $820K | Buy |
6,742
+465
| +7% | +$56.6K | 0.08% | 334 |
|
|
2017
Q1 | $761K | Buy |
6,277
+259
| +4% | +$31.4K | 0.09% | 290 |
|
|
2016
Q4 | $736K | Buy |
6,018
+29
| +0.5% | +$3.55K | 0.1% | 218 |
|
|
2016
Q3 | $734K | Sell |
5,989
-247
| -4% | -$30.3K | 0.11% | 195 |
|
|
2016
Q2 | $728K | Sell |
6,236
-144
| -2% | -$16.8K | 0.11% | 179 |
|
|
2016
Q1 | $889K | Buy |
6,380
+153
| +2% | +$21.3K | 0.2% | 98 |
|
|
2015
Q4 | $1.19M | Buy |
+6,227
| New | +$1.19M | 0.28% | 71 |
|